Wednesday, November 13, 2019 14:00 - Thursday, November 14, 2019 22:00
Sheraton La Jolla, 3299 Holiday Ct, La Jolla 92037, California, United States
The retail cannabis market in North America will soon exceed $25 billion. Though the federal government still classifies cannabis as illegal, 33 states have approved its use for medicinal purposes, and 10 states have made recreational use legal as well. In 2018 Canada became the first nation in the western hemisphere to legalize marijuana for both recreational and medicinal use, making it the largest national market for legal cannabis worldwide. Nevertheless, the state of scientific knowledge on medicinal cannabis remains immature, and the regulatory environment in North America fragmented and contested. That is why you cannot afford to miss Pharma Ed's Canna-Pharma 2019. This two-day event will explicitly link current knowledge and practice in the pharmaceutical and cannabis industries, providing a forum for scientific dialogue aimed at both advancing and applying best practices in this growing field. Research scientists, analytical experts, drug developers, drug device manufactures, cleaning validation experts, cannabis cultivators and labs, and public policy makers will come together to advance the science of cannabis.
Featuring Expert Speakers From
ASTM Committee D37
AOAC Cannabis Working Group
USP Medical Cannabis Expert Committee
International Cannabis & Cannabinoid Institute
Agilent Technologies
Steep Hill Labs
Americans for Safe Access
Medicinal Genomics
University of Maryland
LexKannabis LLC
GBS Global Biopharma
Vas Analytical
Colorado Department of Public Health & Environment
Maryland Medical Cannabis Commission
MCSB, CA Department of Public Health
And Comprehensive Coverage On
Challenges in Creating Standards for Quality Control of Cannabis Derived Products
Updates from Industry Working Groups: ASTM D37, AHPA, USP, & AOAC International
Analytical Testing Strategies for Pesticides, Trace Metals & Other Contaminants
Regulatory Panel Discussion—Hear from the Experts
Cannabis Genetics: The Path to Better Medicinal Cannabis
Hot Topics in Therapeutic Cannabis Research
Key Formulation Considerations for Improved Bioavailability of Cannabinoids
Evaluating the Volatile Constituents of Different Cannabis Varieties using Various Sample Preparation Approaches, and Mass Spec Detection
New Approaches to Pesticide Analysis in Cannabis
Environmental Monitoring for GMP Compliance in Grow Facilities
Cannabis Microbiome Sequencing: Implications for Cannabis Safety Testing
Cleaning Validation and GMPs for Medicinal Cannabis Products
The Therapeutic Potential of Cannabinoid Medicines Applied on the Skin
Intellectual Property Considerations for Medical Cannabis
Buy tickets today!
Like (1)
There are no new feeds to view at this time.